Kidney Failure Raises DKA Stakes
Type 2 diabetes patients with severe kidney disease face deadly hyperglycemic crises. Diabetic ketoacidosis (DKA) kills faster than hyperosmolar hyperglycemic state (HHS) in this group. Nephrologists see both emergencies but lack direct outcome comparisons. This study published in the Journal of Diabetes and its Complications sorts risks using national data.
Massive Database Tracks Real Admissions
Researchers pulled National Inpatient Sample data from 2016 to 2022. They identified adults with T2D plus severe kidney disease. Groups split into DKA with 4773 admissions, HHS with 2179 cases, and 683,079 with neither crisis. In-hospital mortality served as primary outcome. Complications, length of stay, and costs tracked as secondary measures.
DKA Hits Hardest Across Measures
DKA patients faced significantly higher in-hospital death rates than non-crisis controls. Complications piled up more in DKA group. Hospital stays stretched longer for DKA cases. Total hospitalization costs soared highest with DKA too.
HHS Carries Different Dangers
HHS showed increased neurologic events, septic shock, and mechanical ventilation needs versus controls. These risks appeared smaller and less consistent than DKA patterns. HHS burdened patients less severely overall.
Head-to-Head Favors HHS
Direct DKA versus HHS comparison confirmed worse clinical and economic outcomes for DKA. Kidney failure amplifies DKA deadliness beyond HHS effects. Prevention gaps demand immediate attention.
Prevent DKA in Dialysis Patients
Sick day rules become life-saving in severe CKD T2D. Ketone testing kits belong in every dialysis unit. Insulin dose adjustments prevent crises during infections.
Nephrology-Endocrinology Teams Unite
Joint protocols cut DKA admissions through education and monitoring. Bicarbonate use needs prospective testing in kidney failure DKA cases.
Economic Reality Forces Action
DKA triples costs in already expensive CKD admissions. Quality metrics should track hyperglycemic crisis rates by diabetes severity.
Featured
Off
Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
- National Inpatient Sample analysis 2016-2022 identified 4773 DKA, 2179 HHS, and 683,079 non-crisis admissions among T2D patients with severe kidney disease.
- DKA associated with significantly higher in-hospital mortality, more complications, longer length of stay, and greater hospitalization costs compared to non-DKA/HHS controls.
- HHS linked to increased neurologic events, septic shock, and mechanical ventilation requirements versus controls, but differences appeared smaller than DKA effects.
- Direct comparison confirmed DKA imposed substantially greater clinical burden and economic costs than HHS in T2D patients with severe kidney disease.
- Findings highlight urgent need for targeted DKA prevention strategies in vulnerable T2D severe CKD population.
Source
Liang W, Yu H, Deng H, et al. Diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 2 diabetes patients with severe kidney disease: a 7-year retrospective analysis. Journal of Diabetes and its Complications. 2025;40(2):109253-109253. doi: https://doi.org/10.1016/j.jdiacomp.2025.109253
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
National analysis shows DKA triples mortality risk vs no hyperglycemic crisis in 4773 T2D severe CKD admissions, with longer stays and higher costs than HHS (2179 cases).
User Segments
Release Date
Featured Order
0
Is Paid
0
Send Notification
Off